Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells

doi:10.3748/wjg.v17.i25.3002

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5317)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series.

Item

Count

PDF

394

HTML

4543

Figures (1-6)

380

Sum=5317

Jul 7, 2011 (publication date) through Sep 19, 2024

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jul 7, 2011; 17(25): 3002-3011
Published online Jul 7, 2011. doi: 10.3748/wjg.v17.i25.3002

Full Size Figure Download Figure

Figure 3 Intrinsic tumor growth pattern of CT-26 carcinomas in untreated BALB/c WT and nude mice. BALB/c WT (wild type) and BALB/c nu/nu mice were inoculated s.c with 1 × 10⁶ CT-26 cells on Day 7 and tumor size was monitored every other day. The inherent growth patterns in both strains of mice are shown. Each line represents tumor growth in a single mouse.

Citation: Huang X, Chen YT, Song HZ, Huang GC, Chen LB. Cisplatin pretreatment enhances anti-tumor activity of cytokine-induced killer cells. World J Gastroenterol 2011; 17(25): 3002-3011
URL: https://www.wjgnet.com/1007-9327/full/v17/i25/3002.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i25.3002